SCHEMBL10963392

SCHEMBL10963392

CN(C)S(=O)(=O)c1cc(C(=O)CS)ccc1Cl

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 4/20 0.52
▸ SMN1; SMN2 Q16637 2/20 0.52
▸ GSTO1 P78417 6/20 0.52
▸ TSHR P16473 2/20 0.49
▸ CYP1A2 P05177 1/20 0.49
▸ CYP2C19 P33261 1/20 0.49
▸ ALDH1A1 P00352 5/20 0.46
▸ L3MBTL1 Q9Y468 2/20 0.46
▸ MAPK1 P28482 2/20 0.45
▸ BRD4 O60885 1/20 0.44
▸ ATAD2 Q6PL18 1/20 0.44
▸ CECR2 Q9BXF3 1/20 0.44
▸ MEN1 O00255 3/20 0.44
▸ LMNA P02545 2/20 0.44
▸ POLB P06746 1/20 0.44
▸ RAB9A P51151 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11183264 0.87 GSTO1 (0.60) KMT2ASMN1; SMN2GSTO1TSHRCYP1A2
SCHEMBL13545231 0.87 SMN1; SMN2 (0.57) KMT2ASMN1; SMN2GSTO1TSHRCYP1A2
SCHEMBL11598230 0.86 GSTO1 (0.43) KMT2ASMN1; SMN2GSTO1TSHRCYP1A2
SCHEMBL10965917 0.85 KMT2A (0.52) KMT2ASMN1; SMN2GSTO1TSHRCYP1A2
SCHEMBL11342790 0.83 KMT2A (0.53) KMT2ASMN1; SMN2GSTO1TSHRCYP1A2
SCHEMBL11596069 0.81 SMN1; SMN2 (0.54) KMT2ASMN1; SMN2GSTO1TSHRCYP1A2
SCHEMBL11596061 0.81 KMT2A (0.70) KMT2ASMN1; SMN2GSTO1TSHRCYP1A2
SCHEMBL11595745 0.81 GSTO1 (0.57) KMT2ASMN1; SMN2GSTO1TSHRCYP1A2
SCHEMBL11597394 0.81 HDAC3 (0.53) KMT2ASMN1; SMN2GSTO1TSHRCYP1A2
SCHEMBL11597765 0.80 CA1 (0.60) RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0055458-B1 THIAZOLINE DERIVATIVES, THEIR PREPARATION AND USE AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM HOECHST AKTIENGESELLSCHAFT (DE) 1985-02-13 — — EP disclosed
US-4421757-A ANTILIPORPROTEIN IN BLOOD HOECHST AKTIENGESELLSCHAFT (DE) 1983-12-20 — — US disclosed
EP-0023964-B1 PHENYLIMINOTHIAZOLINE DERIVATIVES, THEIR PREPARATION AND INTERMEDIATES THEREFOR, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND THEIR PRODUCTION HOECHST AKTIENGESELLSCHAFT (DE) 1983-02-16 — — EP disclosed
US-4346088-A ANTILIPEMICS HOECHST AKTIENGESELLSCHAFT (DE) 1982-08-24 — — US disclosed
EP-0055458-A2 Thiazoline derivatives, their preparation and use and pharmaceutical preparations containing them HOECHST AKTIENGESELLSCHAFT (DE) 1982-07-07 — — EP disclosed
EP-0023964-A1 Phenyliminothiazoline derivatives, their preparation and intermediates therefor, pharmaceutical preparations containing them and their production HOECHST AKTIENGESELLSCHAFT (DE) 1981-02-18 — — EP disclosed
US-4156735-A SALIDIURETICS HOECHST AKTIENGESELLSCHAFT (DE) 1979-05-29 — — US disclosed
US-4125614-A DIURETIC HOECHST AKTIENGESELLSCHAFT (DE) 1978-11-14 — — US disclosed
US-4118501-A SALIDIURETIC ACTIVITY HOECHST AKTIENGESELLSCHAFT (DE) 1978-10-03 — — US disclosed
US-4061761-A Thiazolidine derivatives HOECHST AKTIENGESELLSCHAFT (DT) 1977-12-06 — — US disclosed
Send feedback